FDA approves new LASIK device

Jul 12, 2007

The U.S. Food and Drug Administration has approved the first LASIK device designed to treat one eye for distance vision and the other eye for close vision.

LASIK -- laser in-situ keratomileusis -- is a procedure in which a surgeon cuts a flap in the outer layers of the cornea, removes a small amount of the tissue beneath it with the laser, and then replaces the flap.

The new device -- CustomVue Monovision LASIK -- produces monovision correction in nearsighted (myopic) adults, with or without astigmatism, ages 40 years or older with normal age-related loss of ability to focus on near objects (presbyopia).

CustomVue is designed to correct all nearsightedness in the patient's dominant eye and only part of the nearsightedness in the non-dominant eye. That allows a person to use the fully corrected eye for distance vision and the under-corrected eye for seeing close up. The brain ultimately adjusts to the difference in perception between the eyes.

CustomVue Monovision LASIK -- manufactured by AMO/VISX Inc. of Santa Clara, Calif. -- is a permanent operation. Side effects can include light sensitivity, night driving glare, ghost images, double vision and visual fluctuation, the FDA said.

Copyright 2007 by United Press International

Explore further: Exploring 3-D printing to make organs for transplants

add to favorites email to friend print save as pdf

Related Stories

First in-situ images of void collapse in explosives

4 minutes ago

While creating the first-ever images of explosives using an x-ray free electron laser in California, Los Alamos researchers and collaborators demonstrated a crucial diagnostic for studying how voids affect ...

NASA maps Typhoon Matmo's Taiwan deluge

14 minutes ago

When Typhoon Matmo crossed over the island nation of Taiwan it left tremendous amounts of rainfall in its wake. NASA used data from the TRMM satellite to calculate just how much rain fell over the nation.

Bacteria manipulate salt to build shelters to hibernate

44 minutes ago

For the first time, Spanish researchers have detected an unknown interaction between microorganisms and salt. When Escherichia coli cells are introduced into a droplet of salt water and is left to dry, b ...

How do we terraform Venus?

44 minutes ago

It might be possible to terraform Venus some day, when our technology gets good enough. The challenges for Venus are totally different than for Mars. How will we need to fix Venus?

Recommended for you

Exploring 3-D printing to make organs for transplants

Jul 30, 2014

Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients ...

High frequency of potential entrapment gaps in hospital beds

Jul 30, 2014

A survey of beds within a large teaching hospital in Ireland has shown than many of them did not comply with dimensional standards put in place to minimise the risk of entrapment. The report, published online in the journal ...

Key element of CPR missing from guidelines

Jul 29, 2014

Removing the head tilt/chin lift component of rescue breaths from the latest cardiopulmonary resuscitation (CPR) guidelines could be a mistake, according to Queen's University professor Anthony Ho.

Burnout impacts transplant surgeons (w/ Video)

Jul 28, 2014

Despite saving thousands of lives yearly, nearly half of organ transplant surgeons report a low sense of personal accomplishment and 40% feel emotionally exhausted, according to a new national study on transplant surgeon ...

User comments : 0